A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics
Translating preclinical safety findings into reliable insights for human risk assessment remains a fundamental challenge in drug development. Prior preclinical-clinical concordance studies have been constrained by limited drug coverage, reliance on identical-term matching for adverse events (AEs), a...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2026-04-01
|
| Serie: | Frontiers in Toxicology |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/ftox.2026.1731947/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|